SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-18-000058
Filing Date
2018-04-30
Accepted
2018-04-30 16:22:19
Documents
5
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A proxynotice2018.htm DEFA14A 18969
2 a02szebligandpharmaceuti001.jpg GRAPHIC 225041
3 a02szebligandpharmaceuti002.jpg GRAPHIC 103067
4 a02szicligandpharmaceuti001.jpg GRAPHIC 206421
5 a02szicligandpharmaceuti002.jpg GRAPHIC 160119
  Complete submission text file 0000886163-18-000058.txt   964117
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 18790105
SIC: 2834 Pharmaceutical Preparations